-transparent.png){kind=logo}
1 Diazoxide 300 mg and labetalol 150 mg were each injected intravenously on separate occasions into five patients with essentail hypertension. The reduction in BP caused by labetalol was slightly greater than that produced by diazoxide. 2 In contrast the reduction in cerebral blood flow (CBF) by labetalol was not statistically significant, whereas diazoxide gave a greater and statistically significant reduction in CBF. 3 These observations suggest that labetalol may have an advantage over diazoxide for the rapid reduction in BP.
| UI | MeSH Term | Description | Entries |
|---|
Related Publications
R M Pearson, and
D N Griffith, and
M Woollard, and
I M James, and
C W Havard
January 1986,
American heart journal,
R M Pearson, and
D N Griffith, and
M Woollard, and
I M James, and
C W Havard
January 1983,
Arquivos brasileiros de cardiologia,
R M Pearson, and
D N Griffith, and
M Woollard, and
I M James, and
C W Havard
January 2002,
Hypertension in pregnancy,
R M Pearson, and
D N Griffith, and
M Woollard, and
I M James, and
C W Havard
January 1981,
Journal of cardiovascular pharmacology,
R M Pearson, and
D N Griffith, and
M Woollard, and
I M James, and
C W Havard
November 1980,
Lijecnicki vjesnik,
R M Pearson, and
D N Griffith, and
M Woollard, and
I M James, and
C W Havard
June 1983,
European journal of clinical investigation,
R M Pearson, and
D N Griffith, and
M Woollard, and
I M James, and
C W Havard
December 1975,
Journal of neurology, neurosurgery, and psychiatry,
R M Pearson, and
D N Griffith, and
M Woollard, and
I M James, and
C W Havard
March 1991,
Neurological research,
R M Pearson, and
D N Griffith, and
M Woollard, and
I M James, and
C W Havard
January 1992,
Journal of cardiovascular pharmacology,
R M Pearson, and
D N Griffith, and
M Woollard, and
I M James, and
C W Havard
May 1982,
British journal of clinical pharmacology,
